Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...

In general, as someone without diabetes, you want your fasting blood sugar (when you haven’t eaten for at least eight hours) to be below 100 mg/dL. You want your spikes to be below 180 mg/dL, to lower ...

This article discusses the best growth stocks to buy right now.

Abbott (NYSE:ABT) is facing an FDA warning letter alleging quality system regulation violations related to FreeStyle Libre ...

Southeast Asia Medical Wearable Devices Market was valued at ~USD 2,080.65 million in 2024 grow at a strong CAGR of ...

Dexcom reports 13% Q4 revenue growth to $1.26B, beating analyst expectations despite mixed analyst ratings and competitive pressures.

New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

Jacob Steven Leach, DexCom, Inc.'s President and CEO who will summarize our recent highlights and ongoing strategic initiatives. Please note that there are also slides available related to our fourth ...

DexCom expects 2026 total revenue to be in a range of $5.16 billion to $5.25 billion, representing growth of 11% to 13% for the year. Sylvain indicated, "This guidance assumes continued strong ...

DexCom Inc. DXCM shares were mostly flat in Thursday's extended trading after the company released its fourth-quarter ...

Smart ring market leader Oura is trying to convince U.S. lawmakers to loosen some health monitoring regulations for wearable ...

Good morning, and thank you for joining ON Semiconductor Corporation's Fourth Quarter and full year 2025 results conference ...